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1. Introduction 
Chromosomal instability  
Cancer is the result of several genetic alterations that overrule a cell’s protection 
mechanisms against unscheduled proliferation (Hanahan & Weinberg, 2000). As the vast 
majority of human tumours show chromosomal instability (CIN), CIN is believed to be an 
important driver and facilitator of oncogenic transformation. CIN can result in structural 
abnormalities such as focal deletions, amplifications or translocations (structural CIN). 
Alternatively, CIN causes numerical abnormalities (i.e. aneuploidy) with cells showing high 
rates of losses and gains of whole chromosomes leading to dramatic karyotypic variability 
between cells. Whereas alterations to single or small groups of oncogenes/ tumour 
suppressor genes can explain the malignant effect of structural CIN, the cancerous effect of 
numerical CIN is mostly attributed to the loss of heterozygosity (LOH) of tumour 
suppressor genes (Jallepalli & Lengauer, 2001, Kops et al., 2005). Structural and numerical 
CIN often coincide in tumours and numerical CIN can in fact provoke structural CIN as 
well (Janssen et al., 2011). Although CIN appears to be a potent driver of genomic 
reorganization, it comes at cost for cells. For instance, numerical CIN in tissue culture cells 
kills cells within six generations (Kops et al., 2004). Furthermore, in depth analysis of 
aneuploid yeast strains and mouse embryonic fibroblasts (MEFs) carrying an extra 
chromosome revealed that aneuploidy slows cell proliferation down and deregulates the 
metabolic homeostasis (Torres et al., 2007, Williams et al., 2008). However, as the majority of 
human tumours are aneuploid, cancer cells must have found a way to circumvent the 
detrimental consequences of CIN. This chapter reviews several mechanisms that can drive 
numerical CIN and discusses several of the mouse models that were engineered to mimic 
these conditions with the aim to study the in vivo consequences of numerical CIN.  
2. Origins of whole chromosome instability 
Kinetochores and centromeric proteins 
Correct chromosome distribution critically depends on correct attachment of chromosomes 
to a bipolar mitotic spindle. Defects in the machinery regulating the formation of a proper 
bipolar spindle have been associated with human cancer and aneuploidy (Fukasawa, 2005, 
Kops et al., 2005, Yuen et al., 2005). Kinetochores are macromolecular protein structures that 
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link the centromeric DNA to the mitotic spindle. The inner kinetochore plate is the DNA 
interacting domain and is comprised of several structural proteins such as the centromeric 
proteins (CENP). Some of these CENP genes (e.g. CENPA, CENPF and CENPH) frequently 
show altered expression in human cancer, underscoring the importance of a precisely 
balanced protein composition of the kinetochore (Yuen et al., 2005). 
The mitotic spindle checkpoint 
To ensure the accurate segregation of chromosomes, cells initiate segregation only after the 
correct attachment of all chromosomes to microtubules of the mitotic spindle. The spindle 
checkpoint (SAC) operates at the outer kinetochore plate by monitoring the attachment of 
the kinetochore to the microtubules. Improperly attached kinetochores recruit a family of 
SAC proteins (Mad1, Mad2, Bub1, BubR1, Bub3, Mps1, Rod and ZW10) (Musacchio & 
Salmon, 2007). Additionally, CENPE, a motor protein, is recruited to unattached 
kinetochores, where it is implicated in regulating microtubule attachment (Kops et al., 2005). 
Even a single unattached kinetochore is sufficient to trigger a robust spindle checkpoint 
response that prevents premature anaphase onset and thus missegregation of chromosomes 
(Rieder et al., 1995, Rieder et al., 1994). This robust response is achieved by CDC20 
sequestering by the SAC proteins, the specificity factor required for anaphase promoting 
complex/cyclosome (APC/C) activity. Activation of the APC/C, an E3 ubiquitin ligase, is 
essential for anaphase progression, as it is responsible for the degradation of several mitotic 
proteins including Securin and Cyclin B1. Securin degradation leads to activation of 
Separase, which cleaves Cohesin that glues sister chromatids together. Cyclin B1 
degradation results in the inactivation of CDK1 and thereby allows mitotic exit (Karess, 
2005, Kops et al., 2005, Musacchio & Salmon, 2007). Thus, precise regulation of APC/C 
activity by the SAC allows for timely and accurate progression of mitosis preventing 
numerical CIN. 
Tension versus attachment 
Kinetochore-microtubule attachment by itself is not sufficient to satisfy the spindle 
checkpoint. To achieve proper segregation, it is also essential that one kinetochore of a pair 
is attached to microtubules from one spindle pole and the other kinetochore to the opposite 
pole (Biggins & Walczak, 2003). This correct geometry of attachment generates tension 
between the sister chromatids, which is another prerequisite for mitotic progression. Aurora 
B is implicated in sensing this tension and correcting erroneous attachments (Andrews et al., 
2003). In the absence of tension, for instance when both sister chromatid kinetochores are 
connected to the same centrosome, Aurora B kinase activity remains uninhibited. This 
results in the release of improper microtubule attachments and allows reattachment of the 
kinetochores with microtubules emanating from the opposite pole (Andrews et al., 2003, Liu 
et al., 2009, Musacchio & Salmon, 2007). While details of error correction mechanisms are 
just emerging, drugs targeting this pathway (e.g. Aurora inhibitors) are already in clinical 
trials for cancer (Jackson et al., 2007). 
Centrosomes 
Centrosomes are essential for bipolar spindle formation during mitosis, as they are the 
major microtubule organizing centres of the cell. The presence of two centrosomes is 
therefore critical for accurate chromosome segregation into two daughter cells. Centrosome 
number is tightly controlled: centrosomes are duplicated during S-phase and segregated 
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into the two daughter cells during mitosis (see for detailed review: (Doxsey et al., 2005, 
Fukasawa, 2005, Nigg, 2007, Tsou & Stearns, 2006) ). Defects in these control mechanisms 
can lead to abnormal centrosome numbers and are thus another cause of numerical CIN. In 
agreement with this, most tumours exhibit abnormal centrosome numbers (Nigg, 2006, 
Pihan et al., 1998). It was originally hypothesized that abnormal centrosome numbers would 
provoke CIN through multipolar mitoses. Although careful tracking revealed that such 
divisions occasionally do take place, the resulting daughter cells all died in the next cell 
cycle. It’s therefore unlikely that cells undergoing multipolar divisions contribute to a 
developing tumour. Instead, in a large proportion of the cells supranumeral centrosomes 
clustered to form one ‘supercentrosome’ allowing ‘normal’ bivalent divisions to take place. 
Such divisions frequently coincided with lagging chromosomes in the next mitosis, 
presumably the result of merotelic attachments caused by abnormal centrosomal structure 
(Ganem et al., 2009). Therefore, lagging chromosomes might very well be the driving force 
behind numerical CIN associated with supranumeral centrosomes. 
3. Mouse models for whole chromosome instability 
To test whether numerical CIN is an early event in tumourigenesis and thereby infer 
whether it can be causative of cancer, several proteins playing a role in accurate segregation 
were disrupted in mice. The results of these studies are discussed below and collectively 
underscore the importance of the spindle checkpoint in the different aspects of 
tumourigenesis. 
Loss of centromeric (CENP) genes frequently causes embryonic lethality 
CENPA, B and C reside at the inner plate of the kinetochore and bridge between the 
centromeric DNA and the kinetochore-docking microtubules emanating from the 
centrosomes. Several of these genes have been knocked out in mice to determine their role in 
the prevention of aneuploidy. Whereas homozygous CENPB loss resulted in no overt 
phenotypes other than slightly lower testis and body weights (Hudson et al., 1998, Kapoor 
et al., 1998, Perez-Castro et al., 1998), disruption of CENPA or CENPC led to embryonic 
lethality in early stages of embryogenesis (E3.5-E6.5). The early embryos show micronuclei, 
a lowered mitotic index (indicative of mitotic delay), and enlarged nuclei (suggestive of 
tetraploid cells). Heterozygous mice develop normally and are fertile, although animals 
were not tested for cancer predisposition using carcinogens or in combination with other 
predisposing mutations (Howman et al., 2000, Kalitsis et al., 1998). Animal longevity and 
spontaneous cancer predisposition are currently being tested [Andy Choo, personal 
communication].  
Spindle checkpoint inactivation interferes with mammalian development 
The first mouse model for germline SAC inactivation was the Mad2 knockout. Homozygous 
Mad2 loss results in embryonic lethality at approximately day E6.5 (Dobles et al., 2000). 
Similar to the Mad2 knockout, BubR1, Bub1, Mad1, Bub3, Rae1 and CENPE inactivation are 
also incompatible with mammalian development beyond day E6.5-E8.5. In all cases, massive 
apoptosis of the inner cell mass (ICM) was observed, presumably a consequence of 
numerous missegregation events in these highly proliferative cells (Baker et al., 2004, Baker 
et al., 2006, Iwanaga et al., 2007, Jeganathan et al., 2007, Kalitsis et al., 2000, Putkey et al., 
2002, Q. Wang et al., 2004, Weaver et al., 2007). Inactivation of the APC/C activating factors 
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Cdc20 or Cdh1 provoke embryonic lethality as well, but later in gestation with embryos 
developing up to E12.5 (Garcia-Higuera et al., 2008, Li et al., 2009).  
The chromosomal passenger proteins Incenp, Survivin and Aurora B are part of the 
chromosomal passenger complex. This complex is essential for forming a bipolar spindle by 
measuring tension during metaphase and is involved in later events in cytokinesis as well 
(Lens et al., 2006). Knockouts for Survivin or Incenp revealed that ablation of either protein 
causes embryonic lethality before day E8.5, similar as observed for CENP proteins and SAC 
protein knockouts (Cutts et al., 1999, Uren et al., 2000).  
Does reduced expression of CIN protective genes result in spontaneous tumour formation? 
Several cancers show decreased expression of spindle checkpoint proteins, indicating that a 
partially compromised checkpoint can be the underlying cause for tumour aneuploidy 
(Weaver & Cleveland, 2006). As homozygous inactivation of SAC components aborts 
embryonic development well before mid-gestation, heterozygous mice (Mad1, Mad2, 
BubR1, Bub1, Bub3, Rae1, Cdc20, Cdh1 and Cenp-E) were used to study the in vivo 
consequences of a partially defective spindle checkpoint. In all cases, heterozygotes are born 
at a Mendelian ratio and none show clear developmental defects, except for a mild 
hematopoietic defect in BubR1 heterozygotes (Babu et al., 2003, Baker et al., 2006, Garcia-
Higuera et al., 2008, Iwanaga et al., 2007, Jeganathan et al., 2007, Kalitsis et al., 2005, Li et al., 
2009, Michel et al., 2001, Q. Wang et al., 2004, Weaver et al., 2007). However, despite normal 
development, Mad2, Mad1 and CENPE heterozygotes develop cancers in a substantial 
number of the animals (20-30%), albeit relatively late (at 18-20 months of age). Lung 
tumours are predominant, and CENPE heterozygotes develop hematopoietic malignancies 
as well (Iwanaga et al., 2007, Michel et al., 2001, Weaver et al., 2007), indicating that Mad1, 
Mad2 and CENPE function as haplo-insufficient tumour suppressors in the mouse by 
suppressing CIN. Heterozygousity for the SAC-downstream-targets Cdh1 or Cdc20 
predisposes for late tumours as well: up to 50% of the Cdc20 hypomorphic mice develop 
tumours, mostly in the hematopoietic compartment, whereas Chd1 heterozygotes mainly 
develop solid tumours in the mammary gland, lungs, liver and testes (Garcia-Higuera et al., 
2008, Li et al., 2009). Heterozygous BubR1, Bub1, Bub3 and Rae1, and even Bub3; Rae1 
double heterozygotes do not develop any malignancies, suggesting that in those models 
aneuploidy is not sufficient for tumours to arise (Baker et al., 2004, Baker et al., 2006, 
Jeganathan et al., 2007, Q. Wang et al., 2004). Finally, similar to SAC knockout 
heterozygotes, Survivin+/- and Incenp+/- mice are indistinguishable from their wildtype 
littermates. Whether these animals are cancer-predisposed is currently not known [Andy 
Choo, personal communication].  
In another approach, a hypomorphic allele for Bub1 was created, reducing protein levels 
down to 20% of wildtype levels. These mice develop several malignancies within 18-20 
months of age, mainly lymphomas, lung and liver tumours (Jeganathan et al., 2007). Using 
the same approach, a hypomorphic allele for BubR1 was engineered (reducing BubR1 
protein levels by 90%). Surprisingly, although these mice develop massive aneuploidy in 
several tissues, they are not cancer-predisposed, suggesting that aneuploidy does not cause 
cancer per se (Baker et al., 2004).  
BubR1 hypomorphs develop another phenotype though: they age prematurely, as 
evidenced by decreased subcutaneous fat and spinal kyphosis (spinal deformation or hump) 
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and muscle atrophy. The median lifespan of these animals is six months and none of them 
age over 15 months (Baker et al., 2004), which might obscure a late-in–life cancer phenotype. 
Bub3; Rae1 double heterozygotes develop a similar phenotype, albeit less severe as these 
animals survive up to 27 months (Jeganathan et al., 2007). Interestingly, BubR1 levels seem 
to decline in aging wildtype tissue, which suggests a role for this gene and possibly 
aneuploidy in natural aging as well (Baker et al., 2004). However, why the premature aging 
phenotype affects these two knockouts and not other aneuploidy-related mouse models is 
currently unknown.  
Phenotypes of the various mouse models are summarized in Table 1. Taken together, the 
results show that SAC defects have a profound effect on development and cancer 
predisposition. Additionally, mouse models targeting the SAC have revealed a potential 
role for aneuploidy in aging.  
Aneuploidy as a collaborating factor in tumorigenesis 
Even though mouse models clearly indicate that numerical CIN can contribute to tumour 
initiation, the actual tumour phenotypes of these mouse models are relatively weak, with 
tumours arising sporadically and relatively late in life. Why is this effect so weak despite the 
high incidence of aneuploidy in human cancer? One explanation is that the current mouse 
models rely on partial inactivation of the spindle checkpoint, since complete inactivation is 
incompatible with embryonic development. Another possible explanation for the weak 
phenotypes is that aneuploidy requires predisposing mutations in order to be tumorigenic 
and therefore plays a more important role in tumour progression. To test the latter hypothesis, 
several of the described models were exposed to carcinogenic drugs or combined with other 
mouse models carrying predisposing mutations in established tumour suppressor genes.  
Indeed, tumour phenotypes are exacerbated by carcinogenic insults. For instance, whereas 
Bub1, Bub3, Rae1 and Bub3; Rae1 double heterozygous mice are not clearly cancer 
predisposed, DMBA treatment (a known carcinogen) provokes more tumours in all four 
knockouts than in wildtype mice (Baker et al., 2006, Jeganathan et al., 2007). This is also true 
for DMBA-treated BubR1 hypomorphs (Baker et al., 2004). Furthermore, BubR1 
heterozygotes are more susceptible to the formation of intestinal tumours in response to 
treatment with the colon carcinogen azoxymethane (Dai et al., 2004). Finally, 40% of Mad1 
heterozygous mice treated with Vinicristine (a microtubule-depolymerizing agent) develop 
tumours whereas control-treated mice do not develop any (Iwanaga et al., 2007). Similarly, 
numerical CIN synergizes with predisposing mutations. For instance, decreased levels of 
Bub1 accelerate tumorigenesis in a p53+/- or Apc+/Min background. In this setting, numerical 
CIN acts by facilitating LOH of the remaining wildtype allele of the tumour suppressor gene 
(Baker et al., 2009).  
Aneuploidy as a tumour suppressor? 
Although decreased levels of Bub1 have a profound effect on tumour initiation in p53- of 
Apc-mutated backgrounds, this synergy is not observed in Rb or Pten heterozygous mice. 
Paradoxically, Bub1 hypomorphism acts tumour suppressive in Pten+/- mice, with Pten+/-; 
Bub1 hypomorphs developing fewer hyperplastic prostate lesions than Pten+/- mice 
expressing wildtype Bub1 levels (Baker et al., 2009). Similarly CENPE heterozygousity 
delays tumourigenesis in a p19Arf-deficient background. Whereas normally p19Arf-/- animals 
develop lymphomas and sarcomas with an average latency of 6-7 months (Kamijo et al., 
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1997), tumour latency is delayed to 12 months in CENPE+/- mice. Furthermore, despite a 
predisposition for hematopoietic malignancies, the number of spontaneous liver tumours in 
CENPE+/- mice is reduced 3-fold and liver tumour sizes are remarkably smaller. Finally, 
CENPE heterozygousity also delays DMBA-induced tumours (Weaver et al., 2007). These 
observations suggest that aneuploidy can delay tumourigenesis as well and that the 
response to aneuploidy might very well be tissue specific.  
Overexpression of genes with a role in chromosome segregation 
Diminished Mad2 expression, mutations and even gene loss do occur in cancer, but are 
infrequent (Percy et al., 2000, X. Wang et al., 2002, X. Wang et al., 2000). More often Mad2 
expression is elevated (Alizadeh et al., 2000, Hernando et al., 2004, van 't Veer et al., 2002). 
This upregulation is likely the result of increased E2F activity in cancers, as the RB 
(retinoblastoma) – E2F pathway is altered in more than 80% of human tumours (Malumbres 
& Barbacid, 2001) and the E2F transcription factor family is an important modulator of 
Mad2 transcription (Hernando et al., 2004). Furthermore, deregulation of the RB pathway 
has been associated with CIN (Lentini et al., 2006, Lentini et al., 2002, Schaeffer et al.,  
2004), and elevated Mad2 levels can provide an explanation for this. Indeed, reducing  
Mad2 protein levels to wildtype levels in Rb deficient cells reduces the number of aneuploid 
cells. Conversely, overexpression of either E2F or Mad2 in wildtype cells increases 
aneuploidy (Hernando et al., 2004). These results strongly suggest that unscheduled 
activation of E2F contributes to aneuploidy through elevated Mad2 expression. To test if this 
is true in vivo, an inducible Mad2 overexpression mouse model was engineered. These mice 
display a wide spectrum of tumours (lung adenomas, lymphomas, hepatocellular 
carcinomas and fibrosarcomas) with a similar latency (~20 months), but higher frequency 
(~50% at 20 months) than Mad2 heterozygous mice (Sotillo et al., 2007). These results seem 
somewhat counterintuitive: why would increasing levels of checkpoint protein lead to 
cancer? Perhaps, delayed degradation of both Securin and Cyclin B1 during mitosis causes 
defects in mitotic exit and thus explains the observed chromosomal aberrations and 
subsequent tumourigenesis. Even though this data indicates a clear role for Mad2 
overexpression in tumorigenesis, several other mechanisms might contribute to the CIN 
phenotype of cells with aberrant E2F activity. For instance, Rb inactivation in mouse 
embryonic fibroblasts also reduces cohesion between sister chromatids, leading to 
premature chromosome segregation and CIN (Coschi et al., 2010, Manning et al., 2010, van 
Harn et al., 2010). Furthermore, inducible overexpression of Hec1, another Rb-interacting 
protein residing at the kinetochore, provokes aneuploid cancers 15-18 months following 
induction (Diaz-Rodriguez et al., 2008) similar to Mad2 overexpressing mice. Therefore, 
even though overexpression of Mad2 has a clear cancer phenotype, it is unlikely that  
Mad2 is the only downstream target of the RB pathway involved in the maintenance of a 
euploid genome. 
Other mouse models for numerical CIN 
Not all aneuploidy is the result of spindle checkpoint failure; other mitotic defects can also 
perturb chromosome segregation and thus cause aneuploidy. Lzts1 was discovered as a 
gene that is frequently lost in breast, lung, gastric, esophageal, prostate, and bladder 
cancers. Lzts1 impairs Cyclin B1 activation late in mitosis, resulting in lowered Cyclin B1-
Cdk1 activity in mitosis and premature mitotic exit, similar to Mad2 overexpression. Indeed, 
Lzts1-deficient mice develop a wide spectrum of tumours within 19 months of age with a 
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high penetrance. Lzts1 loss also facilitates carcinogen-induced tumourigenesis, as NMBA 
treatment resulted in a tumour incidence of 100% in both Lzts1-deficient and heterozygous 
animals, whereas only 15% of the treated control animals develop tumours. Therefore, 
premature mitotic exit through decreased Cyclin B1 levels might be an important driver of 
(numerical) CIN and cancer (Vecchione et al., 2007).  
Entry into mitosis is guarded by a prophase checkpoint that can be activated by 
chromosomal damage or disruption of microtubules (Mikhailov et al., 2002, Pines & Rieder, 
2001). Chfr is a potential E3 ubiquitin ligase that functions early in prophase (Matsusaka & 
Pines, 2004), presumably by controlling expression levels of mitotic proteins such as Aurora 
A. Unlike SAC components, homozygous deletion of Chfr in the mouse is dispensable for 
normal development. However, half of the Chfr-deficient animals develop tumours 
(lymphomas, lung, liver and intestinal tumours) within 20 months of age and furthermore 
the knockouts show accelerated tumour development upon carcinogenic insults (DMBA). 
(Yu et al., 2005). Both phenotypes (Lzts1, Chfr) are very similar to those of the cancer-
predisposed SAC-compromised heterozygotes, emphasizing the importance of accurately 
regulated mitotic kinase activity (Cyclin B1-Cdk1, Aurora A) in preserving normal 
chromosomal numbers and suppression of cancer. 
Micronuclei formation is another indication of chromosomal instability. An elegant genetic 
screen for genes that facilitate micronucleus formation in erythrocytes identified a point 
mutation in Mcm4 (Chaos3). Mcm4 is part of the Mcm2-7 replication licensing complex and 
therefore a crucial part of the DNA replication machinery. Mcm4 mutant mice showed 
decreased expression of several Mcm proteins and primary cells from this mouse also 
showed increased sensitivity for the replication inhibitor aphidicolin in line with a defect in 
DNA replication (Shima et al., 2007). However, as this mutation was identified as a mutation 
that provokes micronuclei formation, this model suggests that defects in DNA replication 
can cause numerical chromosomal abnormalities as well. 
The Adenomatous polyposis coli (APC) gene is a tumour suppressor gene that is often 
mutated in human colorectal cancers (note that this gene is unrelated to the anaphase 
promoting complex APC/C). In addition to APC’s well-known role in 
regulating/dampening β-catenin’s transcriptional activity and cell proliferation, multiple 
lines of evidence indicate that mutated APC contributes to chromosome missegregation and 
numerical CIN. For instance, cell culture studies have shown that APC localizes to 
kinetochores and microtubule ends. Perturbing APC function by mutation, overexpression 
or depletion causes aneuploidy (Draviam et al., 2006, Green et al., 2005, Tighe et al., 2004). In 
addition, mice expressing truncated APC mutant protein display multiple intestinal 
tumours with aberrant mitosis and polyploidy, indicating a strong link between the loss of 
APC’s mitotic function and tumourigenesis (Caldwell et al., 2007, Dikovskaya et al., 2007, 
Oshima et al., 1995, Su et al., 1992). Interestingly, this phenotype can be substantially 
aggravated by concomitant heterozygous BubR1 loss (Rao et al., 2005). Finally, 
transcriptome analysis of APC-mutated cells revealed that the mutation resulted in the 
increase of BubR1 and Mad2 expression, which is also observed in adenomas and colorectal 
carcinomas (Dikovskaya et al., 2007). Together, these findings illustrate an important link 
between deregulation of APC and the proteins that control mitosis in the progression from 
early adenomas to aggressive carcinomas.  
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Lessons learnt from Mouse Embryonic Fibroblasts 
MEFs isolated from several of these mouse models have been invaluable in estimating the 
levels of aneuploidy occurring in vivo. However, as complete ablation of spindle checkpoint 
genes resulted in embryonic lethality before day E8.5 and MEFs are typically isolated at E15.5-
14.5, it has been difficult to generate MEFs from the homozygous knockouts. Therefore 
heterozygous MEFs were analyzed for the extent of aneuploidy (Table I). All heterozygous 
MEFs show significantly elevated numbers of aneuploid cells compared to wildtype control 
MEFs, ranging from 10% aneuploidy in the Mad1+/- MEFs to 50% in the Mad2 heterozygotes 
and Mad2 overexpressing cells. Note that wildtype MEFs typically show less than 10% 
aneuploid cells (Iwanaga et al., 2007, Michel et al., 2001, Sotillo et al., 2007). In addition, BubR1 
hypomorphic and Bub3; Rae1 heterozygous MEFs exhibit premature senescence and increased 
protein levels of senescence-associated p19Arf, p21Cip1 and p16Ink4a (Baker et al., 2004, Baker et 
al., 2006) in agreement with the observed premature aging phenotype.  
Even though all SAC-compromised MEFs show aneuploidy to a greater or lesser extent, the 
level of aneuploidy in MEFs does not fully correlate with cancer incidence (Table I). 
However, aneuploidy analyses might lead to different results depending on the passage 
number of the MEFs. For instance, detailed analysis of Cenp-E heterozygous MEFs revealed 
that up to 70% of the cells are aneuploid at high passage numbers whereas only 20% are 
aneuploid in early passages (Weaver et al., 2007). Furthermore, culturing MEFs in vitro 
might not be the best representation for every cell type in vivo. Therefore, even though MEF 
studies are useful to estimate CIN rates in vitro, in vivo assessment of aneuploidy will be 
crucial to link the extent of aneuploidy to cell fate. 
4. Conclusions 
Aneuploidy as a primary cause for cancer? 
Since the first notion of a possible link between chromosomal abnormalities and malignant 
transformation by Theodore Boveri (Boveri, 1902, Boveri, 1914), we have learned a great 
deal about the causes and consequences of chromosome missegregation. Mouse models 
have provided crucial insight into how the SAC and mitotic machinery protect against CIN 
en cancer. The mouse models discussed in this chapter are far from complete especially as 
structural CIN and numerical CIN appear to be intertwined (Janssen et al., 2011). Therefore, 
mutations in genes protecting against structural CIN (Brca2, Mcm4, p53bp1, etc) might very 
well lead to aneuploidy too, even though these models were not the focus of the current 
chapter.  
Complete inactivation of genes involved in chromosome segregation appears to be 
uncommon in human cancer. Why then is the vast majority of human cancers aneuploid? 
Transcriptome analysis of numerous cancers has revealed that overexpression of spindle 
checkpoint genes is more frequent than reduced expression (Oncomine database (Rhodes et 
al., 2004)). However, in many cases SAC gene products show mutations or truncations 
(Cahill et al., 1998, Kim et al., 2005, Olesen et al., 2001, Percy et al., 2000, Scintu et al., 2007, 
Tsukasaki et al., 2001). Possibly, mutated SAC proteins can act in a dominant-negative 
fashion, and therefore attenuate spindle checkpoint function. Careful biochemical analysis 
of such mutant gene products for their effect on the SAC status in combination with new 
mouse models for these cancer-associated mutations should clarify this issue. 
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Mouse models for systemic SAC inactivation unequivocally show that removing the  
spindle checkpoint is not tolerated during embryonic development, when cells are dividing 
at maximum speed, and results in massive aneuploidy and apoptosis. This agrees fully  
with the observation that SAC inactivation is not tolerated in cancer cell lines (Kops et  
al., 2004). However, p53 inactivation in Mad2 deficient MEFs (derived from Mad2-/-;  
p53-/-embryonic stem cell lines) partly rescues this lethality, as these cell lines show  
better survival  than Mad2-/- MEFs, even though both cell lines become highly aneuploid 
(Burds et al., 2005). Therefore, p53 inactivation might synergize with SAC inactivation  
in malignant transformation by (partly) rescuing SAC-deficiency-induced cell death.  
Indeed, p53 heterozygosity appears to collaborate with Bub1 hypomorphism in 
transformation. 
Partial inactivation of spindle checkpoint genes does not interfere with normal development 
(Table 1) and the average life span of these mice is unaltered. While some heterozygotes 
succumb to tumours at 18-20 months, others age without any cancer phenotype. The Bub3; 
Rae1 double heterozygotes show signs of  premature  aging (but not cancer), but do not 
succumb to the consequences of this phenotype earlier than their wildtype littermates 
(Baker et al., 2006). All together, the current mouse models for CIN argue that aneuploidy 
can provoke cancer. It remains unclear why some models are more prone to cancers than 
other, despite the fact that heterozygous MEFs from all mouse models show substantial 
aneuploidy, where tested. The only effect on life span is observed in BubR1 hypomorphic 
mice, which die a few months earlier due to premature aging (Baker et al., 2004). Premature 
aging coincides with increased numbers of senescent cells in vivo and furthermore, MEFs 
showed increased levels of the senescence-associated p16Ink4a, p19Arf and p21Cip1 proteins.  
Remarkably, in vivo clearance of p16Ink4A positive (i.e. senescent) cells can delay several of 
the premature aging sings in BubR1 hypomorphic mice (Baker et al., 2011), suggesting that 
senescence and aging , in addition to cancer,  are important consequences of (numerical) 
CIN in vivo. 
Premature senescence might also explain why Cenp-E+/- mice are less susceptible to 
tumours in a p19Arf negative background or when tumours were induced chemically 
(Weaver et al., 2007). For instance, loss of p19Arf, an activator of p53 activity, might lead to 
aberrant DNA damage signalling resulting in genomic instability. Similarly, challenging 
animals with carcinogenic compounds will induce CIN. Together with Cenp-E 
heterozygosity, the cumulative aneuploidy might rise to levels that ultimately result  
in senescence, instead of increased proliferation and cancer. These findings emphasize  
once more the importance of studying the relationship between senescence, aneuploidy  
and cancer. 
Future directions 
What are the next steps that will bring us closer to a therapy that specifically  
targets aneuploid cancers? We have now learnt that dramatic numerical CIN (e.g. by  
SAC inactivation) kills cells in vitro and interferes with development in vivo. We also  
now know that aneuploidy deregulates cell metabolism and restricts cell proliferation  
at the cellular level. Partial SAC inactivation appears to predispose for cancer in  
some models and to provoke a progeria/senescence phenotype in others. However, even 
though the vast majority of human tumours are aneuploid, few mutations in the  
SAC cascade have been identified, even though many human cancer cell lines display  
www.intechopen.com
 
Aneuploidy in Health and Disease 
 
68
an abnormal response to anti-cancer drugs that normally activate the SAC, such as 
Paclitaxel. 
Now that several conventional knockout mouse models have been analyzed in depth, we 
need to address more specific questions on the role that aneuploidy plays in cancer, for 
instance: 
- Is full SAC inactivation tolerated in adult tissues and if so, does it require additional 
mutations such as p53 inactivation? 
- What are the consequences of aneuploidy in vivo and do these resemble the 
consequences as found in aneuploid MEFs or yeast strains (Torres et al., 2007, Williams 
et al., 2008)? 
- Which genes collaborate with expansion of aneuploid cell progeny? 
- What determines the cellular response to aneuploidy (proliferation/senescence)? 
- Can we specifically kill aneuploid cells, leaving euploid cells untouched? 
To answer these questions more sophisticated mouse models are required. For instance, to 
answer the first question, conditional mouse models are needed. In such models the 
knockout allele can be deleted in tissues of choice leaving other tissues unaffected. Using 
this approach embryonic lethality can be circumvented in many cases. In addition, such 
models allow for comparing the differential responses to aneuploidy from tissue to tissue 
for each conditional knockout.  
In addition, highly aneuploid tumour panels are required to extract the molecular 
consequences to aneuploidy in transformed cells. For instance, by comparing the molecular 
responses in different aneuploid tumour types (different knockouts, different tissues), 
common responses to aneuploidy can be extracted. Understanding this response is of vital 
importance before even starting to develop drugs that specifically kill aneuploid cells. These 
tumour cohorts can also be used to screen for additional mutations that occurred during 
tumour development. By extracting common mutations occurring in aneuploid tumours 
arising in different tissues and models, recurring pathways can be identified that aneuploid 
cells rely on to survive. With the recent advances in high throughput sequencing technology 
such endeavours are becoming more and more feasible.  
Does this mean that we are still far away from the first therapies that target aneuploid cells? 
Maybe not. A recent study has identified a few promising compounds that specifically 
target aneuploid cell lines making use of the deregulated metabolism of these cells (Tang  
et al., 2011). Such drugs can be tested in an in vivo setting using conditional mouse models 
for CIN. 
Finally, we need a nifty model to visualize aneuploid cells and their response in the  
in vivo setting. One possible approach is to engineer a mouse model in which a single 
chromosome can be tracked, for instance a transgenic mouse strain expressing a fluorescent 
artificial transcription factor. By tracking aneuploidy as it arises in early tumour lesions or in 
aging tissues the direct consequences, but also the more long term effects of aneuploidy  
can be monitored in an in vivo setting. Such a model will provide unique insight into  
a developing tumour or otherwise affected tissue, but, even more important, can  
also be used to visualize the clearance of aneuploid cell progeny in response to newly 
developed drugs.  
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Spindle checkpoint 
genes 
Phenotypes +/- animals 
Genes -/- +/- Cancer prone? 
Chemical 
induced 
cancer? 
Other 
Phenotypes 
Aneuploidy in 
tissue? 
% 
Aneuploid 
MEFs 
Reference 
Bub1 
Embryonic 
lethal (E6.5)
Viable, no 
overt 
developmen
tal defects 
No 
DMBA-
induced 
No ND ND 
(Jeganathan 
et al., 2007) 
Bub1 
hypo-
morph 
NA NA 
50% have 
developed 
tumours by 20 
months 
(lymphomas, 
lung and liver 
tumours) 
ND No ND 
15% 
(segregatio
n defects) 
(Jeganathan 
et al., 2007) 
Bub3 
Embryonic 
lethal (E6.5)
Viable, no 
overt 
developmen
tal defects 
No 
DMBA-
induced 
No 
10% 
(splenocytes)
20% 
(Babu et al., 
2003, Baker 
et al., 2006, 
Kalitsis et 
al., 2000, 
Kalitsis et 
al., 2005) 
Bub3; Rae1 ND 
Viable, no  
overt 
developmen
tal defects 
No 
DMBA-
induced 
Premature 
aging 
40% 
(splenocytes)
40% 
(Babu et al., 
2003, Baker 
et al., 2006) 
BubR1 
Embryonic 
lethal (E6.5)
Viable, no 
overt 
developmen
tal defects 
No 
DMBA-
induced 
Hematopoietic 
defect 
Polyploidy in 
megakaryocy
tes 
15% 
(Baker et al., 
2004, Q. 
Wang et al., 
2004) 
BubR1 
hypo-
morph 
NA NA No 
DMBA-
induced 
and 
azoxymetha
ne induced
Premature 
aging 
30% 
(splenocytes)
35% 
(Baker et al., 
2004) 
Cdc20AAA 
mutant 
(does not 
bind to 
Mad2) 
Embryonic 
lethal (E12.5)
Viable, no 
overt 
developmen
tal defects 
50% of the mice 
developed 
tumours by 24 
months 
ND No 
35% 
(Cdc20AAA/+ , 
splenocytes)
28% of 
Cdc20AAA/+ 
and 52% of 
Cdc20AAA/
AAA 
(Li et al., 
2009) 
Cdh1 
Embryonic 
lethal (E10.5)
Viable, no 
overt 
developmen
tal defects 
17% of the 
females 
develop 
mammary 
tumours 
Tumour 
suppression 
upon 
TPA/DMB
A treatment
No ND 
Increased, 
not further 
quantified 
(Garcia-
Higuera et 
al., 2008) 
CENPE 
Embryonic 
lethal  
(< E7.5) 
Viable, no 
overt 
developmen
tal defects 
20% develop 
tumours by 19-
21 months of 
age (both lung 
and spleen) 
Tumour 
suppression 
upon 
DMBA 
treatment 
Tumour 
suppression in 
a p19Arf-/- 
background 
40% 
(splenocytes)
20% (up to 
70%  at 
high 
passage) 
(Weaver et 
al., 2003, 
Weaver et 
al., 2007) 
Mad1 
Embryonic 
lethal 
Viable, no 
overt 
developmen
tal defects 
20% develop 
tumours within 
18-20 months, 
(lung) 
Vinicristine-
induced 
No ND 10% 
(Iwanaga et 
al., 2007) 
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Mad2 
Embryonic 
lethal (E6.5)
Viable, no 
overt 
developmen
tal defects 
30% develop 
tumours at 18 
months (lung)
ND No ND 55% 
(Dobles et 
al., 2000, 
Michel et al., 
2001) 
Mad2 
over-
expression 
NA NA 
50% develop 
tumours by 20 
months 
(lymphomas, 
lung and liver)
DMBA-
induced 
No 
Aneuploid 
tumours (not 
quantified) 
50% 
(Sotillo et 
al., 2007) 
Rae1 
Embryonic 
lethal (E6.5)
Viable, 
without 
developmen
tal defects 
No 
DMBA-
induced 
No 
10% 
(splenocytes)
20% 
(Babu et al., 
2003, Baker 
et al., 2006) 
Structural 
centromeric proteins 
Phenotypes +/- animals 
 -/- +/- Cancer prone?
Chemical 
induced 
cancer? 
Other 
Phenotypes 
Aneuploidy in 
embryos or 
tissues? 
% 
Aneuploid 
MEFs 
Reference 
CENPA 
Embryonic 
lethal (E6.5)
Viable, 
without  
development
al defects 
ND ND NA 
Chromo-
some 
missegregati
on in E6.5-/- 
embryos 
NA 
(Howman et 
al., 2000) 
CENPB 
Viable, no 
phenotype 
Viable, no 
phenotype 
ND ND 
Lower body 
and testis 
weight 
ND ND 
(Hudson et 
al., 1998, 
Kapoor et al., 
1998, Perez-
Castro et al., 
1998) 
CENPC 
Embryonic 
lethal (E3.5)
Viable, 
without 
development
al defects 
ND ND NA 
Aberrant 
mitosis and 
micronuclei 
in early 
embryos 
NA 
(Kalitsis et 
al., 1998) 
Hec1 
overexpres
sion 
NA NA 
13% develop 
lung tumours 
and 25% 
develop liver 
tumours 15-18 
months after 
induction 
ND No ND 25% 
(Diaz-
Rodriguez et 
al., 2008) 
Chromosomal passenger 
genes/ mitotic spindle 
binding proteins 
Phenotypes +/- animals 
 -/- +/- Cancer prone?
Chemical 
induced 
cancer? 
Other 
Phenotypes 
Aneuploidy in 
embryos/ 
tissues? 
% 
Aneuploid 
MEFs 
Reference 
APC/MIN 
Embryonic 
lethal (<E8.5)
Viable 
Develop 
tumours 
within 3 
months 
(intestine) 
ND 
Anaemia, 
presumably 
due to 
intestinal 
bleeding 
Aneuploidy 
and 
abnormal 
mitosis in 
crypt cells 
Increased, 
not 
quantified 
(Caldwell et 
al., 2007, 
Oshima et 
al., 1995,  
Rao et al., 
2005,  
Su et al., 
1992) 
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Incenp 
Embryonic 
lethal (E3.5- 
8E.5) 
Viable, no 
overt 
development
al defects 
ND ND NA 
Abnormal 
nuclear 
morphology 
hyperdiploid 
content in 
E3.5 embryos
NA 
(Uren et al., 
2000) 
Survivin 
Embryonic 
lethal (E6.5)
Viable, no 
overt 
development
al defects 
ND ND NA 
Giant nuclei 
in early 
embryos 
NA 
(Uren et al., 
2000) 
Genes otherwise 
involved in mitosis 
Phenotypes -/- animals*  
 -/- +/- Cancer prone?
Chemical 
induced 
cancer? 
Other 
Phenotypes 
Aneuploidy in 
tissue? 
Aneuploidy 
in MEFs? 
Reference 
Ltzs1 
Viable, no 
development
al defects 
Viable, no 
develop-
mental 
defects 
All the -/- and 
60% of the +/- 
mice develop 
tumours at 8-
24 months 
(lymphomas, 
mammary, 
liver and liver)
NMBA-
induced 
No ND 
25% 
(lagging 
chromoso
mes) 
(Vecchione et 
al., 2007) 
Mcm4Chaos3 
Mcm4Chaos3/- 
embryonic 
lethal E14.5 
Viable, no 
development
al defects 
Mcm4Chaos3/+ 
develop 
mammary  
tumours 
within a year
ND 
Classic 
minichromoso
me loss 
phenotype in 
blood 
ND ND 
(Shima et al., 
2007) 
Chfr 
Viable, no 
development
al defects 
Viable, no 
develop-
mental 
defects 
50% of the -/- 
animals 
develop 
tumours 
within 20 
months 
DMBA-
induced 
No ND 25% 
(Yu et al., 
2005) 
*in case of Mcm4 mice -/- refers to Mcm4Chaos3/+ mice  
Table 1.  
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